SpringWorks Therapeutics: Q3 Earnings Snapshot
By AP News
Published - Nov 12, 2024, 06:40 AM ET
Last Updated - Dec 16, 2024, 05:30 PM EST
STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Tuesday reported a loss of $53.5 million in its third quarter.
On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 72 cents.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The biopharmaceutical company posted revenue of $49.3 million in the period, which fell short of Street forecasts. Five analysts surveyed by Zacks expected $53.7 million.
